Feds Say Insys Needs Consent To Sell Gov't Deals In Ch. 11

Law360 (August 12, 2019, 7:03 PM EDT) -- The federal government filed an objection in Delaware bankruptcy court Friday to disgraced drugmaker Insys Therapeutics' proposed assignment of Medicaid, Medicare and military contracts in its Chapter 11 sale, saying the contracts can't be sold without government consent.

Insys, whose pharmaceutical arm pled guilty to mail fraud in June in connection with a scheme to bribe doctors, has listed 35 federal contracts among its assets for sale, including rebate agreements under which drug manufacturers reimburse states for discounts offered to eligible patients.

"The debtors may not assume and assign the federal contracts without the United States’ explicit consent," the government said...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS